Lost interest for existing compounds: New boosts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lost interest for existing compounds: New boosts

Published:2015-07 Issue:7 Volume:25 Page:1035-1038
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Friedhoff Lawrence T.,Dailey James

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference16 articles.

1. Alzheimer׳s Association – Latest medication for memory loss –alz.org/alzheimers_disease_standard_prescriptions.asp. (accessed 03.07.14).

2. Bender, Kenneth Iloperidone approved as “second generation” benefits debated, Psychiatric Times 24 August, 2009 〈www.psychiatrictimes.com〉 (accessed 03.07.14).

3. The History of Thalidomide;Botting;Drug News Perspect.,2002

4. Critical Path Institute–c-path.org–(accessed 03.07.14).

5. 15 Years of clinical experience with buproprion HCl: From Buproprion SR to Buproprion XL;Fava;J. Clin. Psychiatry,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing: a systematic review on root causes, barriers and facilitators;BMC Health Services Research;2022-07-29

2. Why promising drugs are shelved and barriers and facilitators to re-purposing them: A systematic literature review;2021-09-29

3. Discovery of novel glyceraldehyde-3-phosphate dehydrogenase inhibitor via docking-based virtual screening;Bioorganic Chemistry;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP